Search Results 1691-1700 of 19032 for Ophthalmic

  1. Melanoma Research Program - Contact Us

    Ophthalmology · Orthopedic Surgery · Otolaryngology · Plastic and Reconstructive Surgery · Radiation Oncology · Radiology · Training and Education; Patient Care

  2. Uveitis Clinical Trials - Mayo Clinic Research

    A Study Of The Safety And Effectiveness Of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution For Non-Infectious Anterior Uveitis Rochester, MN.

  3. Discovery's Edge: Renaissance in medicine - Mayo Clinic News Network

    The Center for Regenerative Medicine is scaling-up regenerative services across medical specialties (from neurology to ophthalmology to sports medicine) and ...

  4. Dry macular degeneration - Doctors and departments - Mayo Clinic

    Ophthalmology · Vitreoretinal Diseases and Surgery Clinic. Research. Mayo Clinic ... Read more about what's happening in ophthalmology research at Mayo Clinic.

  5. Neuromyelitis optica - Doctors and departments - Mayo Clinic

    Neuro-ophthalmology · Ophthalmology · Physical Medicine and Rehabilitation. Areas that research this condition. Neurology Research. Doctors who treat this ...

  6. Doctors and departments - Mayo Clinic

    Ophthalmology. Areas that research this condition. Neurologic Surgery · Neurology Research. Research. Mayo Clinic doctors trained in nervous system conditions ...

  7. Fuchs dystrophy - Doctors and departments - Mayo Clinic

    Mayo Clinic's Department of Ophthalmology has a strong tradition of advanced research to improve the diagnosis and treatment of cornea disorders, and is a ...

  8. Awards - Education Science and Scholarship - Resources for Schools - Academy of Educational Excellence

    Elena Bitrian, M.D., Ophthalmology, Rochester, Minnesota. Katherine Campbell, Ph.D. Regenerative Medicine, Rochester, Minnesota. Paula Craigo, M.D.Opens in new ...

  9. Publications - Clement J. Michet, Jr., M.D. - Mayo Clinic

    Ophthalmology. 1986 May; 93(5):681-9. View PubMed; Michet CJ Jr, Hunder GG. Pericarditis and rheumatic disease. Cardiovasc Rev Rep. 1986 Mar; 7:219-20, 225-8 ...

  10. A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers - Mayo Clinic

    Steroids for topical, ophthalmic, inhaled, or nasal administration are permitted. Physiological replacement with up to a maximum dose of 5 mg equivalence of ...